期刊文献+

新辅助放化疗对直肠/肛管癌患者行经内外括约肌间切除术后近远期疗效的影响 被引量:2

Influence of neoadjuvant chemoradiotherapy on short and long term effects of inter-sphincteric resection for rectal/anal cancer
下载PDF
导出
摘要 目的 探讨新辅助放化疗对直肠/肛管癌患者行经内外括约肌间切除术(ISR)后近远期疗效的影响.方法 直肠/肛管癌患者115例,根据患者术前是否行长周期(8周)新辅助放化疗分组,术前行长周期(8周)新辅助放化疗的患者定义为A组,术前未行长周期(8周)新辅助放化疗的患者定义为B组.两组均行经内外括约肌间切除术(ISR).结果 从术后并发症发生率来看,A组肛周感染率明显高于B组(7.5%vs 0%)(P<0.05).从患者术后肛门功能恢复情况来看,两组术后2、3年肛门功能均较术后1年明显改善(P<0.05).两组间比较,A组术后1、2、3年肛门功能均较B组差(P<0.05).从远期效果来看,两组局部复发率及生存率差异无统计学意义(P>0.05).结论 新辅助化疗联合ISR治疗超低位直肠/肛管癌较单纯ISR,没有延缓患者术后近期恢复,且能够获得相似的生存率及局部复发率,但是,新辅助化疗增加了ISR手术患者术后肛周感染发生率,同时,对患者术后肛门功能造成一定的影响,但仍在患者可接受范围之内. Objective To explore the influence of neoadjuvant chemoradiotherapy on short and long term effects of inter-sphincteric resection (ISR) for patients with rectal/anal cancer.Methods A total of 115 identified patients with rectal/anal cancer who received ISR from January 2009 to October 2009 were retrospectively enrolled.Patients were divided into two groups based on whether they received the preoperative long-term(8 weeks)neoadjuvant chemoradiotherapy or not.Patients with chemoradiotherapy were defined as Group A,and the others were Group B.Results For postoperative complications,perianal infection rate in Group A was obviously higher than Group B(7.5% vs 0%,P < 0.05).Compared with the first year after operation,anal function at the second and third year improved significantly in both groups (P < 0.05).Besides,anal function at the 1 st,2nd and 3rd year after operation in Group A was worse than Group B (P < 0.05).The differences of local recurrence rate and survival rate between the two groups were not significant(P > 0.05).Conclusion Neoadjuvant chemoradiotherapy combined with ISR has not postponed the short-term recovery and it could reach similar survival and local recurrence rates compares with patients who only received ISR.However,neoadjuvant chemoradiotherapy could increase the rate of postoperative perianal infection in rectal/anal cancer patients.Meanwhile,it brought about some impacts on anal function after operation,but they were within the patients' acceptable ranges.
出处 《临床外科杂志》 2014年第4期248-251,共4页 Journal of Clinical Surgery
关键词 新辅助放化疗 直肠 肛管癌 经内括约肌间切除 疗效 neoadjuvant chemoradiotherapy rectal/anal cancer intersphincteric resection curative effect
  • 相关文献

参考文献2

二级参考文献10

共引文献65

同被引文献17

  • 1Lefevre J H, Corte H, Tiret E, et al.Abdominoperineal resection for squarnous cell anal carcinoma: survival and risk factors for recurrence[J]. Ann Surg Oncol,2012,19 (13) :4186-4192.
  • 2Bartelink H, Roelofsen F, Eschwege F, et al.Concomitant radiotherapy and chemotherapy is superior to radiothera- py alone in the treatment of locally advanced anal canc- er:results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Ra- diotherapy and Gastrointestinal Cooperative Groups[J]. J Clin Oncol, 1997,15(5) :2040-2049.
  • 3UKCCCR Anal Cancer Trial Working Party. UK Co-or- dinating Committee on Cancer Research.Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouraeil, and mitomyein[J].Laneet, 1996,348(9034):1049-1054.
  • 4Causey MW, Steele SR, Maykel J, et al. Surgical therapy for epidermoid carcinoma of the anal canal: an NSQIP assessment of short-term outcomes[J]. J Surg Res, 2012,177 (2): 235-240.
  • 5Vieillot S,Fenoglietto P, Lemanski C,et al. IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center[J]. Radiat Oncol, 2012,7: 45.
  • 6Call JA, Prendergast BM, Jensen LG, et al. Intensity- modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study [J]. Am J Clin Oncol,2014:1-4.
  • 7Barmettler H, Komminoth P, Schmid M, et al. Efficacy of cetuximab in combination with FOLFIRI in a patient with KRAS wild-type metastatic anal cancer[J]. Case Rep Oncol,2012,5(2) :428-433.
  • 8Olivatto LO,Vieira FM,Pereira BV,et al.Phase 1 study of cetuximab in combination with 5-fluorouracil,cispla- tin,and radiotherapy in patients with locally advanced anal canal carcinoma[J]. Cancer, 2013,119 (16): 2973- 2980.
  • 9Martellucci J, Naldini G, Colosimo C, et al. Accuracy of endoanal ultrasound in the follow-up assessment for squamous cell carcinoma of the anal canal treated with radiochemotherapy [J]. Surg Endosc, 2009, 23 ( 5 ) : 1054-1057.
  • 10张小龙,高枫,陈利生,刘小健,唐卫中.结直肠肛管癌3197例流行病学分析[J].结直肠肛门外科,2008,14(1):8-11. 被引量:12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部